Cargando…

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants

SIMPLE SUMMARY: Pemphigus is a severe and heterogeneous autoimmune disease determining the formation of blisters in the skin and mucosae. Life quality of patients is indeed deteriorated by the disease. The different kinds of pemphigus are caused by the presence of autoantibodies targeting different...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotti, Roberta, Atene, Claudio Giacinto, Zanfi, Emma Dorotea, Bertesi, Matteo, Pincelli, Carlo, Zanocco-Marani, Tommaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215841/
https://www.ncbi.nlm.nih.gov/pubmed/37237515
http://dx.doi.org/10.3390/biology12050702
Descripción
Sumario:SIMPLE SUMMARY: Pemphigus is a severe and heterogeneous autoimmune disease determining the formation of blisters in the skin and mucosae. Life quality of patients is indeed deteriorated by the disease. The different kinds of pemphigus are caused by the presence of autoantibodies targeting different autoantigens. Many of these are proteins belonging to the Cadherin family that physiologically plays a role in the integrity of skin and mucosae. So far, therapies effectively curing the disease have not been developed and actual strategies are mainly aimed at the control of symptoms. In order to develop specific therapies, efficient disease models are much needed. The most common forms of pemphigus are those characterized by the presence of autoantibodies against the cadherin DSG3 (affecting mainly the mucosae), the cadherin DSG1 (affecting mainly the epidermis), or both simultaneously (mucocutaneous). Here, we present a mouse model where animals can develop the three types of disease. We believe this model, encompassing the three main forms of pemphigus, represents a very robust and needed proving ground for the development of new therapies. ABSTRACT: Background: Pemphigus is a life-threatening blistering autoimmune disease. Several forms, characterized by the presence of autoantibodies against different autoantigens, have been described. In Pemphigus Vulgaris (PV), autoantibodies target the cadherin Desmoglein 3 (DSG3), while in Pemphigus foliaceous (PF) autoantibodies target the cadherin Desmoglein 1 (DSG1). Another variant, mucocutaneous Pemphigus, is characterized by the presence of IgG against both DSG1 and DSG3. Moreover, other forms of Pemphigus characterized by the presence of autoantibodies against other autoantigens have been described. With regard to animal models, one can distinguish between passive models, where pathological IgG are transferred into neonatal mice, and active models, where B cells deriving from animals immunized against a specific autoantigen are transferred into immunodeficient mice that develop the disease. Active models recreate PV and a form of Pemphigus characterized by the presence of IgG against the cadherin Desmocollin 3 (DSC3). Further approaches allow to collect sera or B/T cells from mice immunized against a specific antigen to evaluate the mechanisms underlying the onset of the disease. Objective: To develop and characterize a new active model of Pemphigus where mice express auto antibodies against either DSG1 alone, or DSG1 and DSG3, thereby recapitulating PF and mucocutaneous Pemphigus, respectively. In addition to the existing models, with the active models reported in this work, it will be possible to recapitulate and mimic the main forms of pemphigus in adult mice, thus allowing a better understanding of the disease in the long term, including the benefit/risk ratio of new therapies. Results: The new DSG1 and the DSG1/DSG3 mixed models were developed as proposed. Immunized animals, and subsequently, animals that received splenocytes from the immunized donors produce a high concentration of circulating antibodies against the specific antigens. The severity of the disease was assessed by evaluating the PV score, evidencing that the DSG1/DSG3 mixed model exhibits the most severe symptoms among those analyzed. Alopecia, erosions, and blistering were observed in the skin of DSG1, DSG3 and DSG1/DSG3 models, while lesions in the mucosa were observed only in DSG3 and DSG1/DSG3 animals. The effectiveness of the corticosteroid Methyl-Prednisolone was evaluated in the DSG1 and DSG1/DSG3 models, that showed only partial responsiveness.